Coherus Oncology, Inc.
CHRS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$36 | $298 | -$57 | -$51 |
| Dep. & Amort. | $1 | $1 | $1 | $5 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $3 | $5 | $5 | $6 |
| Change in WC | -$9 | -$24 | $11 | $48 |
| Other Non-Cash | -$6 | -$327 | $13 | $20 |
| Operating Cash Flow | -$46 | -$47 | -$26 | $29 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$69 | -$21 | $0 | $0 |
| Inv. Sales/Matur. | $2 | $0 | $0 | $0 |
| Other Inv. Act. | -$0 | $483 | -$17 | -$1 |
| Investing Cash Flow | -$67 | $463 | -$17 | -$1 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$233 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | -$0 | -$0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$49 | $0 | $0 |
| Financing Cash Flow | $0 | -$282 | -$0 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$114 | $134 | -$44 | $28 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $217 | $83 | $126 | $98 |
| End Cash | $104 | $217 | $83 | $126 |
| Free Cash Flow | -$46 | -$47 | -$26 | $29 |